Nutra Pharma Corp (NPHC)

[mrgoodtrade]

Wednesday, February 06 2013 10:58 AM, EST Amyotrophic Lateral Sclerosis (ALS): Disease Review, Recent Scientific Advancement and Pipeline Analysis - 2012 M2 Communications   "M2 PressWIRE"
Dublin - Research and Markets (http://www.researchandmarkets.com/research/ngbnfs/amyotrophic) has announced the addition of the "Amyotrophic Lateral Sclerosis (ALS): Disease Review, Recent Scientific Advancement and Pipeline Analysis" report to their offering.

For several decades, only minor advancements in Amyotrophic Lateral Sclerosis (ALS) basic research and drug development were seen. With only one FDA -approved drug, which offers few benefits for patients, and very little understanding of the mechanisms underlying ALS, patients and their families remained helpless. Now, it seems like this disease is finally attracting increased attention from both academic researchers and drug developers.

In recent years, basic research has greatly advanced and the clinical pipeline for ALS has never been more varied. Preliminary results from at least two stem cell-based treatments have supplied headlines of ALS patients exhibiting improvement in their clinical status, with others displaying a decreased rate of disease progression.

This report provides an in-depth review of the causes and pathophysiology of ALS, and summarizes the recent advances in basic research towards better understanding this devastating and deadly disease. Current standard of care, as well as an examination of the ALS clinical pipeline are presented.

Companies Mentioned:

- Biogen /Knopp Biosciences

- Mitsubishi Tanabe

- Mayo clinic

- Massachusetts General Hospital

- Eisai

- Cytokinetics

- Massachusetts General Hospital

- Roche/ Ipsen / Insmed

- Charite University , Berlin

- Neuraltus

- Nutra Pharma

- Phoenix Neurological Associates

- Medtronic / NeuroNova / Roche

- Carlo Besta Neurological Institute , Milano

For more information visit http://www.researchandmarkets.com/research/ngbnfs/amyotrophic

CONTACT:

Research and Markets ,

Laura Wood ,

Senior Manager.

[e-mail]

Fax from USA : 646-607-1907

Fax from rest of the world: [phone]

Sector: Healthcare and Medical Devices (http://www.researchandmarkets.com/categories.asp?cat_id=12&campaign_id=ngbnfs)

(( M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [e-mail])).